Published in Ann Surg on March 01, 2001
Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery. JAMA Surg (2015) 2.40
Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol (2009) 1.21
Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum (2012) 1.06
Macroscopic hematuria-a leading urological problem in patients on anticoagulant therapy: is the common diagnostic standard still advisable? ISRN Urol (2012) 0.99
Strategic faculty recruitment increases research productivity within an academic university division. Can J Surg (2009) 0.97
Cancer-associated thrombosis: prevention and treatment. Curr Oncol (2008) 0.95
Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J Surg (2010) 0.94
Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci (2005) 0.94
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology. Nat Clin Pract Oncol (2008) 0.87
The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol (2010) 0.87
Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis. Crit Care (2010) 0.86
Venous thromboembolism in colorectal surgery: skip SCIP or comply? Tech Coloproctol (2014) 0.86
Lower extremity venous thrombosis in patients younger than 50 years of age. Vasc Health Risk Manag (2012) 0.86
Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83
Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Clin Drug Investig (2016) 0.82
Defining incidence and risk factors of venous thromboemolism after hepatectomy. J Gastrointest Surg (2013) 0.82
Cancer-associated thrombosis. Open Cardiovasc Med J (2010) 0.80
Venous thromboembolism prophylaxis. Clin Colon Rectal Surg (2013) 0.80
Cancer and coagulation. Am J Hematol (2012) 0.80
Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol (2015) 0.79
Hepatic veins as a site of clot formation following liver resection. World J Gastroenterol (2011) 0.78
Preoperative evaluation and risk management. Clin Colon Rectal Surg (2009) 0.77
Preoperative evaluation and oncologic principles of colon cancer surgery. Clin Colon Rectal Surg (2005) 0.77
IBD: postoperative VTE prophylaxis in IBD. Nat Rev Gastroenterol Hepatol (2012) 0.76
Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. World J Gastroenterol (2015) 0.76
Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study. Surg Today (2014) 0.75
Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons. HPB (Oxford) (2014) 0.75
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
Low molecular weight heparin in prevention of perioperative thrombosis. BMJ (1992) 3.36
Low-molecular-weight heparins. N Engl J Med (1997) 3.19
Vascular complications of inflammatory bowel disease. Mayo Clin Proc (1986) 3.00
Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg (1970) 2.66
Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ (1992) 2.35
Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg (1992) 2.33
Prevention of venous thromboembolism. Chest (1998) 2.24
Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial. Lancet (1972) 2.20
Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med (1973) 2.17
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med (1998) 2.03
Effect of low-dose heparin on incidence of postoperative pulmonary embolism detected by photoscanning. Lancet (1974) 1.91
Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg (1995) 1.76
Prevention of postoperative deep-vein thrombosis with perioperative subcutaneous heparin. Lancet (1971) 1.55
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg (1997) 1.53
Prevention of venous thrombosis with small, subcutaneous doses of heparin. JAMA (1976) 1.13
Low-dose heparin in postoperative patients: a prospective, coded study. Arch Surg (1975) 0.97
Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost (1995) 0.95
Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials. Haemostasis (1997) 0.92
Drug prevention of postoperative deep vein thrombosis. A compararative study of calcium heparinate and sodium pentosan polysulfate. Arch Surg (1976) 0.92
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg (1995) 0.91
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg (1986) 0.90
Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. Am J Surg (1997) 0.89
125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost (1993) 0.88
Small heparin doses as prophylaxis against deep-vein thrombosis in major surgery. Acta Chir Scand (1975) 0.88
Optimal electrical stimulus for prevention of deep vein thrombosis. Br Med J (1972) 0.86
Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Thromb Haemost (1992) 0.86
Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low-dose heparin. World J Surg (1980) 0.86
Concentrated or diluted heparin prophylaxis of postoperative deep venous thrombosis. Acta Chir Scand (1978) 0.84
Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery. Arch Intern Med (1999) 0.82
International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997. Med Clin North Am (1998) 0.82
Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group. Br J Surg (1991) 0.82
Pulmonary embolism and postoperative death. Acta Chir Scand (1983) 0.80
Fibrinolytic activity in the vein wall after surgery. Br J Surg (1978) 0.80
Diagnosis of deep vein thrombosis in asymptomatic high-risk patients. Haemostasis (1995) 0.80
Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran. Eur J Surg (1995) 0.78
Diagnosis of deep vein thrombosis. Prog Cardiovasc Dis (1994) 0.78
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group. Thromb Haemost (1993) 0.78
Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low-molecular-weight heparin. Arch Surg (1993) 0.78
Use of MEDLINE by physicians for clinical problem solving. JAMA (1993) 6.51
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet (1998) 6.04
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66
Comparison of the ultrastructure of several rickettsiae, ornithosis virus, and Mycoplasma in tissue culture. J Bacteriol (1965) 4.48
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med (2012) 4.21
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med (2001) 4.19
Appendicitis at the millennium. Radiology (2000) 3.70
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (2001) 3.64
Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol (1990) 3.54
Accuracy of clinical assessment of deep-vein thrombosis. Lancet (1995) 3.45
CHANGES IN CHEMICAL COMPOSITION OF THE STEMS OF RED KIDNEY BEAN PLANTS TREATED WITH 2, 4-DICHLOROPHENOXYACETIC ACID. Plant Physiol (1949) 3.33
Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma. Clin Allergy (1978) 3.22
Localization of human immunoglobulin kappa light chain variable region genes to the short arm of chromosome 2 by in situ hybridization. Proc Natl Acad Sci U S A (1982) 3.07
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol (1983) 2.99
The mode of progressive disc cupping in ocular hypertension and glaucoma. Arch Ophthalmol (1980) 2.92
Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol (1974) 2.91
Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol (1995) 2.88
Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol (2001) 2.84
Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ (2014) 2.80
Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum (2000) 2.77
Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet (1997) 2.71
Studies on partially reduced mammalian cytochrome oxidase. Reactions with carbon monoxide and oxygen. Biochem J (1974) 2.67
Radiology reports: examining radiologist and clinician preferences regarding style and content. AJR Am J Roentgenol (2001) 2.63
'Speaking in tongues'. Paradoxical fixation on a non-native language following anaesthesia. Anaesthesia (1999) 2.59
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess (2006) 2.54
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Multiple-organ-failure syndrome. Arch Surg (1986) 2.52
Combined test for assessment of anterior pituitary function. Br Med J (1973) 2.49
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States. Chest (2000) 2.44
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol (2000) 2.43
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost (2010) 2.43
Linking structure and function in glaucoma. Prog Retin Eye Res (2010) 2.43
Immune-related disease and normal-tension glaucoma. A case-control study. Arch Ophthalmol (1992) 2.42
Uterine arteriovenous malformations: gray-scale and Doppler US features with MR imaging correlation. Radiology (1998) 2.42
The reaction of reduced cytochrome C oxidase with oxygen. J Biol Chem (1967) 2.41
Estimates of young children's time with television: a methodological comparison of parent reports with time-lapse video home observation. Child Dev (1985) 2.38
A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis (1992) 2.35
'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess (2008) 2.34
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28
A conserved family of genes related to the testis determining gene, SRY. Nucleic Acids Res (1992) 2.26
Where in the brain does visual attention select the forest and the trees? Nature (1996) 2.24
Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med (1996) 2.22
Three arms: a case study of supernumerary phantom limb after right hemisphere stroke. J Neurol Neurosurg Psychiatry (1993) 2.20
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest (1998) 2.17
Analyzing gene-frequency data when the effective population size is finite. Genetics (1980) 2.15
Left neglect for near but not far space in man. Nature (1991) 2.15
Prediction of school outcomes based on early language production and socioeconomic factors. Child Dev (1994) 2.12
Clinical recognition of glaucomatous cupping. Am J Ophthalmol (1973) 2.08
D-dimer testing is useful to exclude deep vein thrombosis in elderly outpatients. J Thromb Haemost (2008) 2.08
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med (2000) 2.07
Oxygen "pulsed" cytochrome c oxidase: functional properties and catalytic relevance. Proc Natl Acad Sci U S A (1977) 2.06
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation (2004) 2.05
How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03
An unusual intraoperative complication of stapled colorectal anastomosis: report of a case and review of the literature. Can J Surg (1993) 2.00
The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol (1976) 1.97
An evaluation of the API-STREP identification system. Med Lab Sci (1981) 1.97
A purification procedure for the soluble cytochrome oxidase and some other respiratory proteins from Pseudomonas aeruginosa. Biochem J (1976) 1.97
Acid habituation of Escherichia coli and the potential role of cyclopropane fatty acids in low pH tolerance. Int J Food Microbiol (1997) 1.97
Patterns of paralexia: a psycholinguistic approach. J Psycholinguist Res (1973) 1.93
Visuospatial neglect: underlying factors and test sensitivity. Lancet (1989) 1.90
Investigation of genetic linkage between myosin and actin genes using an interspecific mouse back-cross. Nature (1985) 1.89
Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab (2000) 1.87
Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res (1993) 1.83
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut (2003) 1.82
5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology (1984) 1.81
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol (1991) 1.77
The development of the trabecular meshwork and its abnormality in primary infantile glaucoma. Trans Am Ophthalmol Soc (1981) 1.76
A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med (1998) 1.76
The influence of position on intraocular pressure. Invest Ophthalmol (1973) 1.75
The course of axons through the retina and optic nerve head. Arch Ophthalmol (1979) 1.74
Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol (1993) 1.73
Bridging language and cultural barriers between physicians and patients. Public Health Rep (1997) 1.71
Trabecular surgery. Arch Ophthalmol (1974) 1.71
Biological applications of fullerenes. Bioorg Med Chem (1996) 1.70
Screening for fragile X syndrome: a literature review and modelling study. Health Technol Assess (2003) 1.69
Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med (2001) 1.68
Neural mechanisms involved in the processing of global and local aspects of hierarchically organized visual stimuli. Brain (1997) 1.68
Recurrent superior mesenteric artery (Wilkie's) syndrome: a case report. Can J Surg (1996) 1.68
The spectrum of bone disease in end-stage renal failure--an evolving disorder. Kidney Int (1993) 1.68
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int (1995) 1.68
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect (2008) 1.67
Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Ann Surg (1996) 1.66
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Evidence for the existence of two functionally distinct forms cytochrome c manomer at alkaline pH. J Biol Chem (1965) 1.65
Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol (2000) 1.64
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax (2005) 1.64
Straight ileoanal anastomosis v ileal pouch--anal anastomosis after colectomy and mucosal proctectomy. Arch Surg (1983) 1.63
Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol (1998) 1.62
Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg (1997) 1.60
Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol (1969) 1.60